The case is presented of a 31-year-old woman who developed florid clinical
and biochemical Gushing's syndrome due to metastatic hepatic carcinoid tumo
ur from a probable pancreatic primary. Hypercortisolaemia was controlled wi
th metyrapone and ketoconazole, but high doses of octreotide failed to affe
ct plasma cortisol and urinary 5-hyroxyindole acetic acid (5HIAA) levels, o
r prevent rapid tumour growth. Hepatic polystyrene embolisation failed, and
she was treated by liver transplantation with initial excellent results, a
nd normalisation of cortisol and 5HIAA levels. Ten months later, however, s
he relapsed with bony and pelvic tumour recurrence, and high and symptomati
c levels of cortisol and 5HIAA. At this time, octreotide in similar doses t
o those used previously appeared to normalise her biochemically, although s
he died soon after. This variable responsiveness to octreotide could be rel
ated to somatostatin receptor changes, or cyclical tumour secretion pattern
s.